Preview

Complex Issues of Cardiovascular Diseases

Advanced search

CEREBRAL PERFUSION AND CIRCULATION DISTURBANCES. PART III (NON-CONTAST METHODS, RATIONALE AND SAFETY): A REVIEW

https://doi.org/10.17802/2306-1278-2018-7-4-101-111

Abstract

The third part of the review article provides new insights into tissue / cell brain perfusion in chronic cerebral vascular insuffciency, commonly accompanied by polyvascular disease, i.e. stenotic and occlusive lesions of the carotid and coronary arteries. The evaluation of regional cerebral blood flow and cerebrovascular reactivity in the preoperative period of revascularization procedures remains an issue of concern for radiologists. Partly the choice of revascularization strategy, staged or simultaneous revascularization of the carotid and coronary arteries, depends on these parameters. Contrast-enhanced perfusion magnetic resonance imaging (MRI) and computed tomography perfusion (CTP) are commonly associated with a rather high risk of adverse reactions, compared to the widespread single-photon emission computed tomography (SPECT) and arterial spin labelling (ASL) MR perfusion technique, rapidly growing in the last decade. Clinical studies and the introduction of radionuclide diagnostics (SPECT) and non-contrast MR methods (ASL) into routine clinical practice will minimize these risks, while providing clinicians with accurate information on the capacity and cerebral blood flow reserve, which play signifcant role in determining the treatment strategy, similar to the capacity and myocardial blood flow reserve.

About the Authors

S. E. Semenov
Federal State Budgetary Scientifc Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Russian Federation

Semenov Stanislav E., PhD, leading researcher at the Laboratory for Radiology and Tomography Diagnosis

6, Sosnoviy Blvd, Kemerovo, 650002



N. I. Milinevskiy
Federal State Budgetary Scientifc Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Russian Federation

Milinevsky Nikolay I., radiologist

6, Sosnoviy Blvd, Kemerovo, 650002



A. A. Korotkevich
Federal State Budgetary Scientifc Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Russian Federation

Korotkevich Aleksey A., radiologist

6, Sosnoviy Blvd, Kemerovo, 650002



Yu. M. Portnov
Federal State Budgetary Scientifc Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Russian Federation

Portnov Yury M., research assistant at the Laboratory for Radiology and Tomography Diagnosis

6, Sosnoviy Blvd, Kemerovo, 650002



A. S. Semenov
Praxis Wolfgang Theobald Facharzt für Radiologie
Germany

Semenov Alekandr S., resident

31, Lothringer Str., Saarlouis, Saarland, 66740



References

1. Starling E.H. On the absorption of fluids from the connective tissue spaces. The Journal of Physiology. 1896; 19 (4): 312–26. DOI: 10.1113/jphysiol.1896.sp000596.

2. Detre J.A., Rao H., Wang D.J.J., Chen Y.F., Wang Z. Applications of arterial spin labeled MRI in the brain. J Magn Reson Imaging. 2012; 35(5): 1026–1037. DOI: 10.1002/jmri.23581.

3. Semenov S.E., Khromov A.A., Portnov Y.M., Nesterovskiy A.V. The cerebral perfusion of circulation disturbances. Part I (History, the basic postulates and methods of research). Review. Complex Issues of Cardiovascular Diseases. 2016; 5(1): 95-102. (In Russian). DOI: 10.17802/2306-1278-2016-1-95-102.

4. Semenov S.E., Khromov A.A., Portnov Y.M., Nesterovskiy A.V., Khromova A.N., Semenov A.S. The cerebral perfusion of circulation disturbances. Part II (CTand MRI semiotics, patterns of pathological changes). Review. Complex Issues of Cardiovascular Diseases. 2017; 6 (1): 102-111. (In Russian). DOI: 10.17802/23061278-2017-1-102-111.

5. Semenov S., Portnov Yu., Semenov A., Korotkevich A. and Kokov A. Neuroimaging patterns of cerebral hyperperfusion. IOP Conf. Series: Journal of Physics: Conf. Series. 2017; 886: 012014. DOI: 10.1088/1742-6596/886/1/012014.

6. Lukyanenok P.I., Usov V.Yu., Semenov S.E., Portnov Yu.M. Structure and functional evaluation of brain in patients with arterial hypertension according to diagnostic imaging and its influence on choice of treatment tactics. International journal of applied and fundamental research. 2017; 8(1): 66-68. (In Russian).

7. Portnov Yu.M., Semenov S.E., Khromova A.N., Zhuchkova E.A., Khromov A.A., Kokov A.N. et al. Manifestations of reperfusion syndrome after coronary artery bypass grafting according to the data of CT-cerebral perfusion. Klinicheskaya fziologiya krovoobrashcheniya. 2012; 4: 39-42. (In Russian).

8. Kornienko V.N., Pronin I.N. Diagnosticheskaya nejroradiologiya. Moscow; 2006. (In Russian).

9. Gorokhov A.S., Kozlov B.N., Kuznetsov M.S., Shipulin V. M. Combined atherosclerotic lesions of coronary and carotid arteries: choice of surgical strategy based on brain functional reserve assessment. Complex Issues of Cardiovascular Diseases. 2013; (3): 50-56. (In Russian). DOI: 10.17802/2306-1278-2013-3-50-56.

10. Shevchenko Yu.L., Popov L.V., Batrashev V.A., Baykov V.Yu. Rezul'taty khirurgicheskogo lecheniya patsientov s sochetannym ateroskleroticheskim porazheniem koronarnykh i brakhiotsefal'nykh arteriy. Vestnik Natsional'nogo mediko-khirurgicheskogo Tsentra im. N.I. Pirogova. 2014; 9(1): 14-17. (In Russian).

11. Torma N., Sihotsky V., Kopolovets I.I., Frankoviсova M., Sabol F., Kubikova M., Stefanic P. The Results of Simultaneous Operations in Patients with Atherosclerotic Lesions of Carotid and Coronary Arteries. Novosti Khirurgii. 2015; 23(2): 171-175. (In Russian).

12. Mozharovskaya M.A., Badul M.I., Morozov S.P., Krizhanovsky S.M., Shmirjev V.I. Perfusion computerized tomography of the brain for diagnosing acute and chronic cerebral bloodflow disorders. Kremlevskaya meditsina. Klinicheskiy vestnik. 2012; 3: 20-24. (In Russian).

13. Weber M.A., Gunther M., Lichy M.P., Delorme S., Bongers A., Thilmann C. et al. Comparison of arterial spin labeling techniques and dynamic susceptibility weighted contrast enhanced MRI in perfusion imaging of normal brain tissue. Invest. Radiol. 2003; 38(11): 712–718.

14. Goetti R., O’Gorman R., Khan N., Kellenberger C.J., Scheer I. Arterial spin labelling MRI for assessment of cerebral perfusion in children with moyamoya disease: comparison with dynamic susceptibility contrast MRI. Neuroradiology. 2013; 55(5): 639-647. DOI: https://doi.org/10.1007/s00234-013-1155-8.

15. Sierra-Marcos A. Review article. Regional cerebral blood flow in mild cognitive impairment and Alzheimer’s disease measured with arterial spin labeling. Magnetic Resonance Imaging. International Journal of Alzheimer’s Disease. 2017; 5479597. DOI: https://doi.org/10.1155/2017/5479597.

16. Ostergaard L., Sorensen A. G., Kwong K. K., Weisskoff R. M., Gyldensted C., Rosen B. R. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: experimental comparison and preliminary results. Magn. Reson. Med. 1996; 36 (5): 726–736. DOI: 10.1002/mrm.1910360511.

17. Palkowitsch P.K., Bostelmann S., Lengsfeld P. Safety and tolerability of iopromide intravascular use: a pooled analysis of three non-interventional studies in 132,012 patients. Acta Radiol. 2014; 55 (6): 707–14. DOI: 10.1177/0284185113504753.

18. Hunt C.H., Hartman R.P., Hesley G.K. Frequency and severity of adverse effects of iodinated and gadolinium contrast materials: retrospective review of 456930 doses. Am J Roentgenol. 2009; 193 (4): 1124–7. DOI: 10.2214/AJR.09.2520.

19. Hesse B., Vinberg N., Berthelsen A.K., Ballinger J.R. Adverse events in nuclear medicine – cause for concern? Eur J Nucl Med Mol Imaging. 2012; 39: 782–785. DOI: 10.1007/s00259-012-2071-6.

20. Hesslewood S.R. European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 2000. Eur J Nucl Med Mol Imaging. 2002; 29 (5): 13–9. DOI: 10.1007/s00259-002-0771-z.

21. Laroche M.-L., Quelven I., Mazère J., Merle L. Adverse reactions to radiopharmaceuticals in France: analysis of the national pharmacovigilance database. Annals of Pharmacotherapy. 2015; 49 (1): 39–47. DOI: 10.1177/1060028014558153.

22. Silindir M., Özer A.Y. Adverse reactions to radiopharmaceuticals (ARRP): particularly to technetium radiopharmaceuticals. FABAD J. Pharm. Sci. 2008; 33: 109–117.

23. Kennedy-Dixon T.G., Gossell-Williams M., Cooper M., Trabelsi M. and Vinjamuri S. Evaluation of radiopharmaceutical adverse reaction reports to the British Nuclear Medicine Society for the period 2007 to 2016. J Nucl Med. 2017; Dec; 58 (12): 2010– 2012. DOI: 10.2967/jnumed.117.194092.

24. Deibler A.R., Pollock J.M., Kraft R.A., Tan H., Burdette J.H., Maldjian J.A. Arterial spin-labeling in routine clinical practice. Part 1. Technique and artifacts. AJNR. 2008; 29 (7): 1228–34. DOI: https://doi.org/10.3174/ajnr.A1030.

25. Demin D.S., Vasilkiv L.M., Tulupov A.A. Current state of MRI perfusion in cerebral blood flow measurement. Vestnik Novosibirskogo gosudarstvennogo universiteta. Seriya: Biologiya, klinicheskaya meditsina. 2015; 13 (4): 47–56. (In Russian).

26. Grade M., Hernandez Tamames J.A., Pizzini F.B., Achten E., Golay X., Smits M.A neuroradiologist’s guide to arterial spin labeling MRI in clinical practice. Neuroradiology. 2015; 57 (12): 1181–1202. DOI 10.1007/s00234-015-1571-z.

27. Kaneta T., Katsuse O., Hirano T., Ogawa M., Shihikura-Hino A., Yoshida K. et al. Voxel-wise correlations between cognition and cerebral blood flow using arterial spinlabeled perfusion MRI in patients with Alzheimer’s disease: a cross-sectional study. BMC Neurology. 2017; 17: 91. DOI: 10.1186/s12883-017-0870-x.

28. Kamano H, Yoshiura T, Hiwatashi A., Abe K., Togao O., Yamashita K., Honda H. Arterial spin labeling in patients with chronic cerebral artery steno-occlusive disease: correlation with 15O-PET. Acta Radiol. 2013; 54 (1): 99–106. DOI: https://doi.org/10.1258/ar.2012.120450.

29. Martin S.Z., Madai V.I., von Samson-Himmelstjerna F.C., Mutke M.A., Bauer M., Herzig C.X. et al. 3D GRASE pulsed arterial spin labeling at multiple inflow times in patients with long arterial transit times: comparison with dynamic susceptibility-weighted contrast-enhanced MRI at 3 tesla. J Cereb Blood Flow Metab. 2015; 35 (3): 392–401. DOI: https://doi.org/10.1038/jcbfm.2014.200.

30. Deibler A.R., Pollock J.M., Kraft R.A., Tan H., Burdette J.H., Maldjian J.A. Arterial spin-labeling in routine clinical practice. Part 2. Hypoperfusion patterns. AJNR. 2008; 29(7): 1235–41. DOI: https://doi.org/10.3174/ajnr.A1033.

31. Dai W., Garcia D., de Bazelair C., Alsop D.C. Continuous flow driven inversion for arterial spin labeling using pulsed radio frequency and gradient felds. Magn. Res. Med. 2008; 60 (6): 1488–1497. DOI: 10.1002/mrm.21790.

32. Deibler A.R., Pollock J.M., Kraft R.A., Tan H., Burdette J.H., Maldjian J.A. Arterial spin labeling in routine clinical practice, Part 3: Hyperperfusion patterns. AJNR. 2008; 29 (8): 1428–1435. DOI: https://doi.org/10.3174/ajnr.A1034.

33. Pronin I.N., Fadeeva L.M., Podoprigora A.E., Zakharova N.E., Serkov S.V., Rodionov P.V. et al. Arterial spin labeling (ASL): method of cerebral blood flow visualization and quantifcation. Luchevaya diagnostika i terapiya. 2012; 3: 64–78. (In Russian).

34. Zaharchuk G., El Mogy I.S., Fischbein N.J., Albers G.W. Comparison of arterial spin labeling and bolus perfusion-weighted imaging for detecting mismatch in acute stroke. Stroke. 2012; 43: 7: 1843–1848. DOI: https://doi.org/10.1161/STROKEAHA.111.639773.

35. Chalela J.A., Alsop D.C., Gonzalez-Atavales J.B., Maldjian J.A., Kasner S.E., Detre J.A. Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling. Stroke. 2000; 31 (3): 680–687. DOI: https://doi.org/10.1161/01.STR.31.3.680.

36. Kang K.M., Sohn C.-H., Kim B.S., Kim Y.I., Choi S.H., Yun T.J. et al. Correlation of asymmetry indices measured by arterial spin-labeling MR imaging and SPECT in patients with crossed cerebellar diaschisis. AJNR. 2015; 36 (9): 1662–68. DOI: https://doi.org/10.3174/ajnr.A4366.

37. Ogasawara K., Ogawa A., Yoshimoto T. Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study. Stroke. 2002; 33 (7): 1857–1862. DOI: https://doi.org/10.1161/01.STR.0000019511.81583.A8.

38. Catafau A.M. Brain spect in clinical practice. Part 1: perfusion. J Nucl Med. 2001; 42 (2): 259–271.

39. Jain R., Hoeffner E.G., Deveikis J.P., Harrigan M.R., Thompson B.G. Mukherji S.K. Carotid perfusion CT with balloon occlusion and acetazolamide challenge test: feasibility. Radiology. 2004; 231 (3): 906–913. DOI: https://doi.org/10.1148/radiol.2313030093.

40. Ogasawara K., Ogawa A., Terasaki K., Shimizu H., Tominaga T., Yoshimoto T. Use of cerebrovascular reactivity in patients with symptomatic major cerebral artery occlusion to predict 5-year outcome: comparison of xenon-133 and iodine-123-IMP single-photon emission computed tomography. J Cereb Blood Flow Metab. 2002; 22 (9): 1142–48. DOI: https://doi.org/10.1097/00004647-200209000-00012.

41. Vagal A.S., Leach J.L., Fernandez-Ulloa M., Zuccarello M. The acetazolamide challenge: techniques and applications in the evaluation of chronic cerebral ischemia. AJNR. 30 (5): 876–84. DOI 10.3174/ajnr.A1538.

42. Lupanov V.P. Comparative evaluation of functional methods in the diagnosis of coronary artery disease. Ateroskleroz i dislipidemii. 2011; 2: 18–25. (In Russian).

43. Efmova N., Chernov V., Efmova I., Akhmedov Sh., Lishmanov Yu. Changes in cerebral blood flow and cognitive function in patients undergoing coronary bypass surgery with cardiopulmonary bypass. Kardiologiya. 2015; 55 (6): 40–46. (In Russian).

44. Volkov S.V., Sharypova T.N., Smirnov A.M., Sinitsyn V.E., Lyadov K.V. Possibility of an emission computer tomography for an estimation cerebral perfusion at patients with carotid stenoses before and after stenting. Vestnik rentgenologii i radiologii. 2008; 4 (6): 4–10. (In Russian).

45. Kuznetsov M.S., Kozlov B.N., Nasrashvili G.G., Panflov D.S., Plotnikov M.P., Andriyanova A.V., Shipulin V.M. Analysis of the surgical outcomes of combined atherosclerotic lesions of carotid and coronary arteries. Complex Issues of Cardiovascular Diseases. 2016; 5 (3): 35–42. (In Russian). DOI: 10.17802/2306-1278-2016-3-35-42.

46. Chernyavsky A.M., Edemsky A.G., Chernyavsky M.A., Vinogradova T.E. Hybrid technologies in surgical treatment of patients with concomitant atherosclerotic lesions of carotid and coronary arteries. Patologiya krovoobrashcheniya i kardiokhirurgiya. 2013; 17 (1): 45–53. (In Russian). DOI: http://dx.doi.org/10.21688/1681-3472-2013-1-45-53.

47. Portnov Yu.M., Semenov S.E., Kokov A.N. PCT in assessment of cerebral hemodynamics in coronary artery disease patients undergoing on-pump CABG. Sibirskiy meditsinskiy zhurnal (g. Tomsk). 2016; 31(2): 34-37. (In Russian).

48. Yen Y.-F., Field A.S., Martin E.M., Ari N., Burdette J.H., Moody D.M. et al. Test-retest reproducibility of quantitative CBF measurements using FAIR perfusion MRI and acetazolamide challenge. Magn Reson Med. 2002; 47 (5): 921–28. DOI: 10.1002/mrm.10140.

49. Arbab A.S., Aoki S., Toyama K., Miyazawa N., Kumagai H., Umeda T. et al. Quantitative measurement of regional cerebral blood flow with flow-sensitive alternating inversion recovery imaging: comparison with [Iodine 123]-iodoamphetamin single photon emission CT. AJNR. 2002; 23 (3): 381–88.

50. Wolf R.L., Detre J.A. Clinical neuroimaging using arterial spin_labelled perfusion magnetic resonance imaging. Neuropediatrics. 2007; 4 (3): 346–359. DOI: https://doi.org/10.1016/j.nurt.2007.04.005.


Review

For citations:


Semenov S.E., Milinevskiy N.I., Korotkevich A.A., Portnov Yu.M., Semenov A.S. CEREBRAL PERFUSION AND CIRCULATION DISTURBANCES. PART III (NON-CONTAST METHODS, RATIONALE AND SAFETY): A REVIEW. Complex Issues of Cardiovascular Diseases. 2018;7(4):101-111. (In Russ.) https://doi.org/10.17802/2306-1278-2018-7-4-101-111

Views: 829


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2306-1278 (Print)
ISSN 2587-9537 (Online)